S47445 15mg

DRUG2 trials

Sponsors

Institut de Recherches Internationales Servier

Conditions

Alzheimer's DiseaseMajor Depressive Disorder

Phase 2

Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms

CompletedNCT02626572

Institut de Recherches Internationales ServierAlzheimer's Disease

Start: 2015-02-28End: 2017-09-30Target: 500Updated: 2024-07-25

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

CompletedNCT02805439

Institut de Recherches Internationales ServierMajor Depressive Disorder

Start: 2016-03-31End: 2017-04-30Updated: 2020-01-03